Virtus LifeSci Biotech Products ETF (BBP)

Assets	$23.95M
Expense Ratio	0.79%
PE Ratio	n/a
Shares Out	400,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1,695
Open	61.65
Previous Close	62.54
Day's Range	60.80 - 61.73
52-Week Low	48.65
52-Week High	69.12
Beta	0.53
Holdings	57
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

21.45% of assets

Name	Symbol	Weight
CRISPR Therapeutics AG	CRSP	2.59%
Rhythm Pharmaceuticals, Inc.	RYTM	2.51%
Ardelyx, Inc.	ARDX	2.20%
Ionis Pharmaceuticals, Inc.	IONS	2.14%
Moderna, Inc.	MRNA	2.13%
BridgeBio Pharma, Inc.	BBIO	2.06%
Agios Pharmaceuticals, Inc.	AGIO	2.01%
Travere Therapeutics, Inc.	TVTX	1.94%
Theravance Biopharma, Inc.	TBPH	1.94%
Mirum Pharmaceuticals, Inc.	MIRM	1.94%

Performance

BBP had a total return of 1.16% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.94%.